Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 165.2 Billion JPY | 14.42% |
| 2023 | 143.43 Billion JPY | 18.52% |
| 2022 | 121.01 Billion JPY | 15.1% |
| 2021 | 105.13 Billion JPY | -0.16% |
| 2020 | 105.3 Billion JPY | 4.46% |
| 2019 | 100.8 Billion JPY | 1.82% |
| 2018 | 99 Billion JPY | 8.85% |
| 2017 | 90.95 Billion JPY | 1.08% |
| 2016 | 89.98 Billion JPY | 11.7% |
| 2015 | 80.55 Billion JPY | -2.31% |
| 2014 | 82.46 Billion JPY | 24.01% |
| 2013 | 66.49 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 37.27 Billion JPY | -6.37% |
| 2024 Q2 | 40.32 Billion JPY | 8.17% |
| 2024 Q3 | 41.46 Billion JPY | 2.83% |
| 2024 FY | 165.2 Billion JPY | 15.18% |
| 2024 Q4 | 46.13 Billion JPY | 11.26% |
| 2023 Q2 | 35.43 Billion JPY | 10.49% |
| 2023 FY | 143.43 Billion JPY | 18.52% |
| 2023 Q4 | 39.81 Billion JPY | 10.28% |
| 2023 Q3 | 36.1 Billion JPY | 1.88% |
| 2023 Q1 | 32.07 Billion JPY | -9.52% |
| 2022 Q3 | 29.89 Billion JPY | 4.25% |
| 2022 Q2 | 28.67 Billion JPY | 6.22% |
| 2022 FY | 121.01 Billion JPY | 15.1% |
| 2022 Q1 | 26.99 Billion JPY | -9.65% |
| 2022 Q4 | 35.44 Billion JPY | 18.57% |
| 2021 Q2 | 24.95 Billion JPY | 3.95% |
| 2021 FY | 105.13 Billion JPY | -0.16% |
| 2021 Q3 | 25.99 Billion JPY | 4.17% |
| 2021 Q1 | 24 Billion JPY | -18.93% |
| 2021 Q4 | 29.87 Billion JPY | 14.95% |
| 2020 Q4 | 29.61 Billion JPY | 6.06% |
| 2020 FY | 105.3 Billion JPY | 4.46% |
| 2020 Q3 | 27.91 Billion JPY | 10.66% |
| 2020 Q2 | 25.22 Billion JPY | -6.81% |
| 2020 Q1 | 27.07 Billion JPY | -3.45% |
| 2019 Q3 | 25.83 Billion JPY | 2.09% |
| 2019 FY | 100.8 Billion JPY | 1.82% |
| 2019 Q1 | 24.71 Billion JPY | -20.08% |
| 2019 Q2 | 25.3 Billion JPY | 2.4% |
| 2019 Q4 | 28.03 Billion JPY | 8.52% |
| 2018 Q3 | 23.15 Billion JPY | -3.52% |
| 2018 FY | 99 Billion JPY | 8.85% |
| 2018 Q1 | 22.97 Billion JPY | -9.73% |
| 2018 Q4 | 30.92 Billion JPY | 33.54% |
| 2018 Q2 | 24 Billion JPY | 4.46% |
| 2017 Q2 | 22.81 Billion JPY | 2.33% |
| 2017 Q3 | 22.59 Billion JPY | -0.94% |
| 2017 Q4 | 25.45 Billion JPY | 12.66% |
| 2017 FY | 90.95 Billion JPY | 1.08% |
| 2017 Q1 | 22.29 Billion JPY | -17.12% |
| 2016 FY | 89.98 Billion JPY | 11.7% |
| 2016 Q3 | 23.74 Billion JPY | -2.64% |
| 2016 Q2 | 24.38 Billion JPY | 12.26% |
| 2016 Q1 | 21.72 Billion JPY | -3.9% |
| 2016 Q4 | 26.89 Billion JPY | 13.27% |
| 2015 Q1 | 19.42 Billion JPY | -13.85% |
| 2015 Q4 | 22.6 Billion JPY | 15.66% |
| 2015 Q3 | 19.54 Billion JPY | 2.99% |
| 2015 Q2 | 18.97 Billion JPY | -2.29% |
| 2015 FY | 80.55 Billion JPY | -2.31% |
| 2014 Q2 | 19.74 Billion JPY | 0.24% |
| 2014 FY | 82.46 Billion JPY | 24.01% |
| 2014 Q4 | 22.54 Billion JPY | 10.11% |
| 2014 Q3 | 20.47 Billion JPY | 3.7% |
| 2014 Q1 | 19.69 Billion JPY | 10.3% |
| 2013 Q3 | 16.01 Billion JPY | 0.17% |
| 2013 Q2 | 15.98 Billion JPY | 0.0% |
| 2013 FY | 66.49 Billion JPY | 0.0% |
| 2013 Q4 | 17.85 Billion JPY | 11.49% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -5769412.179% |
| Ansell Limited | 495.5 Million USD | -33240.061% |
| Ansell Limited | 495.5 Million USD | -33240.061% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -199407.788% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -9544861.855% |
| Psykey, Inc. | 1.21 Million USD | -13613638.999% |
| ConvaTec Group Plc | 910.31 Million USD | -18047.549% |
| ConvaTec Group Plc | 872.5 Million USD | -18834.097% |
| Encision Inc. | 3.77 Million USD | -4374036.988% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -116492978.816% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -150275982.27% |
| Innovative MedTech Inc. | 6.09 Million USD | -2708540.317% |
| LifePoint, Inc. | 7.42 Million USD | -2225154.483% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -2601884.564% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -19321537.427% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -22750521.786% |
| Reflect Scientific, Inc. | 1.06 Million USD | -15530609.345% |
| SmileDirectClub, Inc. | 517 Million USD | -31853.393% |
| Sector 10, Inc. | 39.84 Thousand USD | -414616906.325% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -2386.816% |
| SheerVision, Inc. | 2.33 Million USD | -7085056.982% |
| United Health Products, Inc. | 2.42 Million USD | -6807950.478% |
| Vasamed, Inc. | 4.67 Million USD | -3535167.287% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -6448480.766% |
| Yubo International Biotech Limited | 1.25 Million USD | -13133160.459% |